101. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes
- Author
-
Isabel Rodríguez-Escudero, Víctor J. Cid, Amparo Andrés-Pons, María D. Oliver, Rafael Pulido, and María Molina
- Subjects
DNA Mutational Analysis ,Molecular Sequence Data ,Mutagenesis (molecular biology technique) ,Saccharomyces cerevisiae ,Biology ,medicine.disease_cause ,Germline ,Structure-Activity Relationship ,Phosphatidylinositol Phosphates ,Catalytic Domain ,Genetics ,medicine ,Tensin ,PTEN ,Humans ,Amino Acid Sequence ,Autistic Disorder ,Molecular Biology ,Protein kinase B ,Genetics (clinical) ,PI3K/AKT/mTOR pathway ,Loss function ,Germ-Line Mutation ,Mutation ,Aspartic Acid ,Alanine ,PTEN Phosphohydrolase ,General Medicine ,Phosphoric Monoester Hydrolases ,Mutagenesis ,Cancer research ,biology.protein ,Hamartoma Syndrome, Multiple - Abstract
The PTEN (phosphatase and tensin homolog) phosphatase is unique in mammals in terms of its tumor suppressor activity, exerted by dephosphorylation of the lipid second messenger PIP(3) (phosphatidylinositol 3,4,5-trisphosphate), which activates the phosphoinositide 3-kinase/Akt/mTOR (mammalian target of rapamycin) oncogenic pathway. Loss-of-function mutations in the PTEN gene are frequent in human cancer and in the germline of patients with PTEN hamartoma tumor-related syndromes (PHTSs). In addition, PTEN is mutated in patients with autism spectrum disorders (ASDs), although no functional information on these mutations is available. Here, we report a comprehensive in vivo functional analysis of human PTEN using a heterologous yeast reconstitution system. Ala-scanning mutagenesis at the catalytic loops of PTEN outlined the critical role of residues within the P-catalytic loop for PIP(3) phosphatase activity in vivo. PTEN mutations that mimic the P-catalytic loop of mammalian PTEN-like proteins (TPTE, TPIP, tensins and auxilins) affected PTEN function variably, whereas tumor- or PHTS-associated mutations targeting the PTEN P-loop produced complete loss of function. Conversely, Ala-substitutions, as well as tumor-related mutations at the WPD- and TI-catalytic loops, displayed partial activity in many cases. Interestingly, a tumor-related D92N mutation was partially active, supporting the notion that the PTEN Asp92 residue might not function as the catalytic general acid. The analysis of a panel of ASD-associated hereditary PTEN mutations revealed that most of them did not substantially abrogate PTEN activity in vivo, whereas most of PHTS-associated mutations did. Our findings reveal distinctive functional patterns among PTEN mutations found in tumors and in the germline of PHTS and ASD patients, which could be relevant for therapy.
- Published
- 2011